Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00870948 · ClinicalTrials.gov registry record · Phase 1
Phase 1 BA Study, Single Center With Healthy Volunteers
A Phase 1 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 1
- Development phase
- 75
- Enrollment target
NCT00870948 is a Phase 1 study that has completed, run by Abbott. The registered enrollment target is 75 participants.
The verdict
NCT00870948, a Phase 1 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 75 participants
- Enrollment target
Study Summary
Single dose in healthy volunteers to assess bioavailability (amount of study drug in the system) between different formulations of ABT-874.
Interventions
- DRUG ABT-874
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2009-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00870948
The ClinicalTrials.gov registry entry for NCT00870948 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ABT-874 is the first listed.
NCT00870948 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00870948 about?
NCT00870948 is a clinical study titled "Phase 1 BA Study, Single Center With Healthy Volunteers". Single dose in healthy volunteers to assess bioavailability (amount of study drug in the system) between different formulations of ABT-874.
What is the current status of trial NCT00870948?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 75 participants. The study started on 2009-01.
What interventions are being tested in trial NCT00870948?
The interventions under investigation include: ABT-874 (DRUG).
Who is sponsoring clinical trial NCT00870948?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.